Delivers robust growth, PAT growth of 26.0 per cent YoY to Rs 225 crore
Global Health has announced its unaudited consolidated financial results for the quarter and nine months ending 31st December, 2022.
Highlights of the nine months ended 31st December, 2022 (9M FY2023)
- Total Income of Rs 20,273 million; growth of 21.2 per cent YoY
- EBITDA of Rs 4,856 million; growth of 22.1 per cent YoY
- EBITDA margins slightly improved to 24.0 per cent compared to 23.8 per cent in 9M FY22
- Profit after tax of Rs 2,250 million; growth of 26.0 per cent YoY
- Installed bed capacity increased by 167 beds; 65 beds added in Lucknow and 102 beds in Patna
- Occupied bed days increased by 10.7 per cent YoY. In-patient occupancy stood at 59 per cent on increased bed capacity
- ARPOB increased by 8.5 per cent to Rs 58,494 and ALOS improved by 16.1 per cent to 3.2 days
- In-patient footfall of over 1 lakh, up by 31.9 per cent and out-patient footfall of over 1.7 million, up by 12.3 per cent
Highlights of the quarter ended 31st December, 2022 (Q3 FY2023)
- Highest ever quarterly total income of Rs 7,062 million; growth of 19.0 per cent YoY
- EBITDA of Rs 1,719 million; growth of 17.9 per cent YoY
- Healthy EBITDA margins at 24.3 per cent
- Profit after tax of Rs 806 million; growth of 15.3 per cent YoY
- Occupied bed days increased by 13.5 per cent YoY. In-patient occupancy stood at 59 per cent on increased bed capacity
- ARPOB increased by 4.3 per cent to Rs 58,367 and ALOS improved to 3.3 days
- In-patient footfall of ~ 35,000+, up by 23.1 per cent and out-patient footfall of ~5.5Lakh+, up by 16.0 per cent
- Advertisement -